Vanguard Group Inc Atara Biotherapeutics, Inc. Transaction History

Vanguard Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.44 - $1.22 $736,166 - $2.04 Million	-1,673,105 Reduced 25.02%	5,012,938 $3.46 Million
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $18,425 - $139,391	80,110 Added 1.21%	6,686,043 $3.41 Million
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $479,961 - $786,319	-340,398 Reduced 4.9%	6,605,933 $9.78 Million
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $136,717 - $277,080	91,145 Added 1.33%	6,946,331 $11.2 Million
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $996,413 - $1.94 Million	-355,862 Reduced 4.93%	6,855,186 $19.9 Million
Q4 2022 Feb 10, 2023	BUY	$2.85 - $5.18 $1.72 Million - $3.13 Million	604,539 Added 9.15%	7,211,048 $23.7 Million
Q3 2022 Nov 14, 2022	SELL	$2.85 - $8.73 $1.97 Million - $6.04 Million	-691,564 Reduced 9.48%	6,606,509 $25 Million
Q2 2022 Aug 12, 2022	BUY	$4.69 - $9.84 $1.81 Million - $3.79 Million	385,499 Added 5.58%	7,298,073 $56.9 Million
Q1 2022 May 13, 2022	SELL	$8.44 - $16.89 $1.38 Million - $2.75 Million	-162,947 Reduced 2.3%	6,912,574 $64.2 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $19.89 $4.04 Million - $5.47 Million	274,938 Added 4.04%	7,075,521 $112 Million
Q3 2021 Nov 12, 2021	BUY	$11.99 - $17.9 $1.16 Million - $1.73 Million	96,442 Added 1.44%	6,800,583 $122 Million
Q2 2021 Aug 13, 2021	BUY	$12.89 - $16.58 $86.4 Million - $111 Million	6,704,141 New	6,704,141 $104 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.25B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.